Convalescent Plasma Futile as Treatment for Critically Ill Covid Patients
In the earliest days of the COVID-19 pandemic, the medical community turned to a century-old treatment: Take blood from recovered patients and give it
Stay updated with breaking news from While Doing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the earliest days of the COVID-19 pandemic, the medical community turned to a century-old treatment: Take blood from recovered patients and give it
This study compares the effect of convalescent plasma vs no convalescent plasma on the outcome of organ support–free days in the hospital among critically ill a
(File photo) Article continues below advertisement ↴ An international trial tested in over 300 hospitals around the world have concluded that blood thinners improve the outcome for hospitalized COVID-19 patients. The University of Manitoba released the conclusion of the trials in a media release on Friday. The introduction of full-dose blood thinners for patients who had mild symptoms of the virus showed a reduced need for organ support. The release says that three clinical trial platforms spanning five continents in over 300 hospitals have been working together since May 2020 to ...